Chemoinformaics analysis of ACETIC-ACID-2-METHYL-BUTYL-ESTER
| Molecular Weight | 130.187 | nRot | 4 |
| Heavy Atom Molecular Weight | 116.075 | nRig | 1 |
| Exact Molecular Weight | 130.099 | nRing | 0 |
| Solubility: LogS | -1.756 | nHRing | 0 |
| Solubility: LogP | 2.337 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 22.6291 |
| nHD | 0 | BPOL | 16.6489 |
| QED | 0.428 |
| Synth | 1.633 |
| Natural Product Likeliness | 0.71 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.004 |
| HIA | 0.003 |
| CACO-2 | -4.265 |
| MDCK | 0.000031 |
| BBB | 0.996 |
| PPB | 0.480886 |
| VDSS | 0.954 |
| FU | 0.678416 |
| CYP1A2-inh | 0.961 |
| CYP1A2-sub | 0.333 |
| CYP2c19-inh | 0.368 |
| CYP2c19-sub | 0.571 |
| CYP2c9-inh | 0.1 |
| CYP2c9-sub | 0.268 |
| CYP2d6-inh | 0.042 |
| CYP2d6-sub | 0.201 |
| CYP3a4-inh | 0.026 |
| CYP3a4-sub | 0.23 |
| CL | 6.626 |
| T12 | 0.711 |
| hERG | 0.038 |
| Ames | 0.01 |
| ROA | 0.031 |
| SkinSen | 0.662 |
| Carcinogencity | 0.373 |
| EI | 0.991 |
| Respiratory | 0.115 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.950564 |